Source: Allergan ($AGN) thinks facial injectable Kybella has the potential to one day bank Botox-level sales. And the company is starting up a couple new studies to help it get there. The Dublin drugmaker is initiating trials of the med in bra-line fat and fat around the knees and ankles,…...